Mark S. Litwin

Active 1994–2025

121
Papers
26,306
Citations
86
h-index
115
i10-index

Citations

Citations per year for Mark S. Litwin1968: 1 citations1980: 1 citations1995: 5 citations1996: 18 citations1997: 34 citations1998: 36 citations1999: 57 citations2000: 79 citations2001: 135 citations2002: 153 citations2003: 172 citations2004: 134 citations2005: 185 citations2006: 147 citations2007: 190 citations2008: 219 citations2009: 230 citations2010: 251 citations2011: 183 citations2012: 169 citations2013: 169 citations2014: 177 citations2015: 133 citations2016: 125 citations2017: 110 citations2018: 105 citations2019: 469 citations2020: 431 citations2021: 435 citations2022: 267 citations2023: 201 citations2024: 340 citations2025: 122 citations2026: 3 citations1969–1979: no citations, so these years are not shown1981–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,215 citing papers, 36.1% of this breakdownCanada: 452 citing papers, 7.4% of this breakdownUnited Kingdom: 426 citing papers, 6.9% of this breakdownChina: 416 citing papers, 6.8% of this breakdownItaly: 309 citing papers, 5% of this breakdownGermany: 264 citing papers, 4.3% of this breakdownNetherlands: 188 citing papers, 3.1% of this breakdownAustralia: 187 citing papers, 3.1% of this breakdownFrance: 156 citing papers, 2.5% of this breakdownSweden: 106 citing papers, 1.7% of this breakdownSwitzerland: 92 citing papers, 1.5% of this breakdownSpain: 87 citing papers, 1.4% of this breakdown
0%36.1%Other 20.2%

Fields

  • Medicine79.8%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Health Professions2.6%
  • Social Sciences1.6%
  • Computer Science1.6%
  • Economics, Econometrics and Finance1%
  • Other6%

Topics

  • Prostate Cancer Diagnosis and Treatment12.9%
  • Prostate Cancer Treatment and Research8.7%
  • Urinary Bladder and Prostate Research5.2%
  • Cancer survivorship and care4.9%
  • Sexual function and dysfunction studies3.5%
  • Bladder and Urothelial Cancer Treatments3.3%
  • Other61.5%

Coauthors

All papers

Open in search
  1. The Diagnosis and Treatment of Prostate Cancer

    Authors: , - JAMA 2017 cited by 1,455

  2. THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE: A STRAIGHTFORWARD AND RELIABLE PREOPERATIVE PREDICTOR OF DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY

    Authors: , , , , , , - The Journal of Urology 2005 cited by 769

  3. Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 2,261

  4. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

    Authors: , , , , - Urology 2000 cited by 1,506

  5. Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Irving Kaplan, Martin G. Sanda - Urology 2014 cited by 334

  6. Recurrence of high‐risk bladder cancer: A population‐based analysis

    Authors: , , , , , , , , - Cancer 2013 cited by 377

  7. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care

    Authors: , , , , , , , , , , , , , , , , , , - European Urology 2022 cited by 76

  8. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008

    Authors: , , , , , , , - Cancer 2016 cited by 350

  9. Effect of Gender-affirming Facial Feminization Surgery on Psychosocial Outcomes

    Authors: , , , , , , , , , - Annals of Surgery 2022 cited by 87

  10. Renal and cardiovascular morbidity after partial or radical nephrectomy

    Authors: , , , , - Cancer 2007 cited by 289

  11. Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma In Situ of the Bladder

    Authors: , , , , , , , , , - The Journal of Urology 2020 cited by 35

  12. THE NATIONAL INSTITUTES OF HEALTH CHRONIC PROSTATITIS SYMPTOM INDEX: DEVELOPMENT AND VALIDATION OF A NEW OUTCOME MEASURE

    Authors: , , , , , , , , - The Journal of Urology 1999 cited by 953

  13. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

    Authors: , , , , , - Cancer 2007 cited by 541

  14. Use of Radical Cystectomy for Patients With Invasive Bladder Cancer

    Authors: , , , , , , , , - JNCI Journal of the National Cancer Institute 2010 cited by 280

  15. Expanded Prostate Cancer Index Composite for Clinical Practice: Development and Validation of a Practical Health Related Quality of Life Instrument for Use in the Routine Clinical Care of Patients With Prostate Cancer

    Authors: , , , , , , , , , , , , , , - The Journal of Urology 2011 cited by 194

  16. Validation of a Modified National Institutes of Health Chronic Prostatitis Symptom Index to Assess Genitourinary Pain in Both Men and Women

    Authors: , , , , , , - Urology 2009 cited by 194

  17. Measuring and Predicting Prostate Cancer Related Quality of Life Changes Using EPIC for Clinical Practice

    Authors: , , , , , , , - The Journal of Urology 2013 cited by 80

  18. Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial

    Authors: , , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2022 cited by 48

  19. The UCLA Prostate Cancer Index

    Authors: , , , , , - Medical Care 1998 cited by 837

  20. Prediction of Erectile Function Following Treatment for Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA 2011 cited by 317

  21. UROLOGIC DISEASES IN AMERICA PROJECT: ANALYTICAL METHODS AND PRINCIPAL FINDINGS

    Authors: , , , , , , , , , , , - The Journal of Urology 2005 cited by 254

  22. Comorbidity and competing risks for mortality in men with prostate cancer

    Authors: , , , , , , - Cancer 2011 cited by 108

  23. Mortality increases when radical cystectomy is delayed more than 12 weeks

    Authors: , , , , - Cancer 2009 cited by 235

  24. Demographic And Clinical Characteristics Of Men With Chronic Prostatitis: The National Institutes Of Health Chronic Prostatitis Cohort Study

    Authors: , , , , , , , , , , , , , , , , - The Journal of Urology 2002 cited by 223